PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Review Article

Volume 2 Issue 4

Biopsychosocial Approach to the Treatment of Chronic Urological Pelvic Pain Syndrome

AI Melehin*

March 15, 2023

Abstract

Using the example of modern biopsychosocial urological models, the article shows that the syndrome of chronic urological pelvic pain has a multi-factorial Genesis and requires an integrative, multidisciplinary approach (urologist, neurologist, and clinical psychologist).In this regard, the identification of individual urological clinical phenotypes of patients allows us to identify predisposing, provoking and supporting factors that determine the course of the disease and the response to therapy. The phenotypic urological systems are described: Marr, UPOINT, and DABBEC. The specifics of mental comorbidity (depression, panic disorder, borderline personality disorder, etc.) in this group of urological patients are detailed. The Association of symptoms of depression and changes in sexual functioning with urological chronic pelvic pain syndrome is shown. For the first time, the models of urinary-bladder-bowel-brain by L. Karsten are described; accumulated stress and falsification of anxiety, loss of control in patients with urological pelvic pain by D. Dasalakis and models of the influence of the patient's mental state on muscle-tonic manifestations in the urological clinic of Yaong Ki. Personal characteristics of patients with urological pelvic pain neuroticism, compliance, openness, conscientiousness, conscientiousness, changes in masculine identity, alexithymia, catastrophization) are systematized and described. The tactics of conducting a full and rapid comprehensive psychological assessment of a urological patient are presented.

Keywords: chronic prostatitis; chronic pelvic pain syndrome; prostatitis; biopsychosocial approach; catastrophization, neuroticism; depression

References

  1. Brown TA and Rosellini AJ. “The direct and interactive effects of neuroticism and life stress on the severity and longitudinal course of depressive symptoms”. Journal of Abnormal Psychology 120.4 (2011): 844-56.
  2. Khan A and Murphy A. “Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome”. World Journal of Pharmacology 4.1 (2015): 1-16.
  3. Nickel JC. “Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)”. World Journal of Urology 31.4 (2013): 709-710.
  4. Shoskes DA and Nickel JC. “Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system”. World Journal of Urology 31.4 (2013): 755-760.
  5. Potente C., et al. “Evaluation of the effectiveness of rehabilitation treatment in patients with chronic pelvic pain: a systematic review”. Pelviperineology 38 (2019): 70-77.
  6. Nickel JC, Shoskes DA and Wagenlehner FM. “Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact”. World Journal of Urology 31.4 (2013): 747-753.
  7. Tripp DA., et al. “Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study”. BJU international 94.9 (2009): 1279-1282.
  8. Doiron RC, Shoskes DA and Nickel JC. “Male CP/CPPS: where do we stand?”. World Journal of Urology 37.6 (2019): 1015-1022.
  9. Nickel JC., et al. “Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome”. BJU international 101.1 (2008): 59-64.
  10. Chung SD, Huang CC and Lin HC. “Chronic prostatitis and depressive disorder: a three-year population-based study”. Journal of Affective Disorders 134.1-3 (2011): 404-409.
  11. Ahn SG., et al. “Depression, anxiety, stress perception, and coping strategies in Korean military patients with chronic prostatitis/chronic pelvic pain syndrome”. Korean journal of urology 53 (2012): 643-658.
  12. Anderson RU., et al. “Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome”. Journal of Urology 179 (2008): 956-960.
  13. Melekhin AI. “Gynecological and urological chronic pelvic pain: tactics of cognitive-behavioral psychotherapy”. neurodynamics. Journal of Clinical Psychology and Psychiatry 4 (2019): 47-63.
  14. Egan JK and Krieger JN. “Psychological problems in chronic prostatitis patients with pain”. The Clinical Journal of Pain 10.3 (1994): 218-226.
  15. Kwon JK and Chang IH. “Pain, catastrophizing, and depression in chronic prostatitis/chronic pelvic pain syndrome”. International neurourology journal 17.2 (2013): 48-58.
  16. Mehik A., et al. “Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross- sectional study in Finland”. BJU international 88.1 (2001): 35-38.
  17. Koh JS., et al. “The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study”. Journal of Psychosomatic Research 76.2 (2014): 127-133.
  18. Leue C., et al. “Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis”. Nature Reviews Urology 14.3 (2017): 153-163.
  19. Berghuis J.P., et al. “Psychological and physical factors involved in chronic idiopathic prostatitis”. Journal of Psychosomatic Research 41.4 (1996): 313-325.
  20. Ullrich PM., et al. “Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain”. Annals of Behavioral Medicine 30.2 (2005): 112-118.
  21. Sullivan MJ., et al. “Theoretical perspectives on the relation between catastrophizing and pain”. The Clinical Journal of Pain 17.1 (2001): 52-64.
  22. Potente C., et al. “Evaluation of the effectiveness of rehabilitation treatment in patients with chronic pelvic pain: a systematic review”. Pelviperineology 38 (2019): 70-77.
  23. Pirola GM., et al. “Chronic prostatitis: current treatment options”. Research and reports in urology 11 (2019): 165-174.
  24. Shoskes DA and Nickel JC. “Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system”. World Journal of Urology 31.4 (2013): 755-760.
  25. Seung Wook Lee. “Recent trend of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) management”. Hanyang Medical Reviews 37.1 (2017): 40-46.
  26. Nickel JC, Mullins C and Tripp DA. “Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome”. World Journal of Urology 26 (2008): 167-72.
  27. Nickel JC and Shoskes DA. “Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome”. BJU International 106.9 (2010): 1252-1263.
  28. Allsop SA., et al. “The DABBEC phenotyping system: towards a mechanistic understanding of CP/CPPS”. Nature Reviews Urology 8 (2011): 107-11.
  29. Melehin AI. “Cognitive behavioral therapy in the complex treatment of chronic prostatitis and pelvic pain syndrome”. Digest of Urology 5 (2019): 26-32.
  30. Melehin AI. “Cognitive-behavioral psychotherapy of chronic pelvic pain syndrome: specifics of its implementation and effectiveness”. Experimental and clinical urology 1 (2020): 80-96.
  31. Miller HC. Stress prostatitis. Urology 32.6 (1988): 507-510.
  32. Keltikangas-Jaervinen L., Ruokolainen J and Lehtonen T. “Personality pathology underlying chronic prostatitis”. Psychotherapy and Psychosomatics 37 (1982): 87-95.
  33. Naliboff BD., et al. “Clinical and psychosocial predictors of urological chronic pelvic pain symptom change in 1 year: a prospective study from the MAPP Research Network”. The journal of urology 198 (2017): 848-857.
  34. Daskalakis NP., et al. “The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome”. Psychoneuroendocrinology 38.9 (2013): 1858-1873.
  35. Brown TA and Rosellini AJ. “The direct and interactive effects of neuroticism and life stress on the severity and longitudinal course of depressive symptoms”. Journal of Abnormal Psychology 120.4 (2011): 844-56.
  36. Tripp DA., et al. “Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome”. The Journal of Pain 7.10 (2006): 697-708.
  37. Moussas G., et al. “Alexithymia association with chronic prostatitis”. European Psychiatry 24 (2009): 19-28.
  38. Sousa N. “The dynamics of the stress neuromatrix”. Molecular psychiatry 21 (2016): 302-312.
  39. Tripp DA. “Managing psychosocial correlates of urologic chronic pelvic pain syndromes: Advice from a urology pain psychologist”. Canadian Urological Association Journal 12.6 (2018): 175-177.
  40. Brünahl CA., et al. “Combined Cognitive-Behavioural and Physiotherapeutic Therapy for Patients with Chronic Pelvic Pain Syndrome (COMBI-CPPS): study protocol for a controlled feasibility trial”. Trials 19.1 (2018): 20-29.
  41. Clemens JQ., et al. “Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network”. Nature Reviews Urology 16.3 (2019): 187-200.